产品名称 | NebuSelect™ Recombinant Cynomolgus TRAIL R2/DR5/TNFRSF10B, His-tag |
---|---|
目录号 | NBL-241591 |
别名 | TRAIL R2/DR5/TNFRSF10B |
外观 | see COA |
分子量 | |
CAS | N/A |
溶解度 | Water Soluble |
存储条件 | Short term 4℃; Long term -20℃. |
保存时间 | 2 years |
备注1 | A0A2K5TXK0 |
备注2 |
目录号 | 规格 | 价格 | 库存状态 | |
NBL-241591-100ug | 100ug | Inquire | Inquire | |
NBL-241591-1mg | 1mg | Inquire | Inquire | |
NBL-241591-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Cynomolgus TRAIL R2/DR5/TNFRSF10B, His-tag
Catalog#:
NBL-241591
Description:
NebuSelect™ Recombinant Cynomolgus TRAIL R2/DR5/TNFRSF10B, His-tag(Cat#NBL-241591) is expressed in HEK293 with His tag at the C-Terminus.It contains Ile58-Ser212.
Species:
Cynomolgus
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 18.28 kDa. Due to glycosylation, the protein migrates to 25-35 kDa based on Bis-Tris PAGE result.
Target Name:
TRAIL R2/DR5/TNFRSF10B
Target Information:
DR5, also called TRAIL R2, TRICK 2, TNFRSF10B, and MK is a type 1 TNF R superfamily, membrane protein which is a receptor for TRAIL (APO2 ligand). DR5 is a receptor for the cytotoxic ligand TNFSF10/TRAIL. The resulting death-inducing signaling complex (DISC) performs caspase-8 proteolytic activation which initiates the subsequent cascade of caspases (aspartate-specific cysteine proteases) mediating apoptosis.
Amino Acid Sequence:
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.